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INTRODUCTION 
Paediatric respiratory disease remains an important cause of 
morbidity in both the developing and the developed world. It has become 
the most common reason parents cite for taking their children to see the 
general practitioner, and for attendance to the emergency department with 
a paediatric medical problem1. 
Community acquired pneumonia (CAP) refers to an infection of the 
lung by a variety of microorganisms acquired outside the hospital setting, 
resulting in inflammation of the lung tissue. It is typically associated with 
fever and respiratory symptoms such as cough and tachypnoea, but 
symptoms may be non-specific in young children. Radiographic changes 
may be useful to confirm the diagnosis. It remains an important cause of 
death in children throughout the world, especially in developing countries. 
The groups at highest risk of long term morbidity and mortality include 
infants (especially low birth weight or premature), those who are immune 
compromised, and those who have other underlying conditions such as 
malnutrition or congenital heart disease. 
Despite pneumonia being a condition commonly encountered by 
clinicians, uncertainty remains over the diagnosis, investigation, and 
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treatment of the condition. The British Thoracic Society (BTS) and WHO 
have published clinical guidelines which provide evidence base for the 
management of CAP2. The guidelines recognize, however, that there are 
still some recommendations based on consensus opinion due to the lack of 
available evidence.  
Epidemiology  
Acute respiratory infections (ARIs) continue to be the leading cause 
of acute illnesses worldwide and remain the most important cause of infant 
and young children mortality, accounting for about two million deaths each 
year 3,4,5and ranking first among causes of disability-adjusted life-years 
(DALYs) lost in developing countries (94.6 millions, 6.3% of total)6 . The 
populations most at risk for developing a fatal respiratory disease are the 
very young, the elderly, and the immune compromised. While upper 
respiratory infections (URIs) are very frequent but seldom life-threatening, 
lower respiratory infections (LRIs) are responsible for more severe 
illnesses such as influenza, pneumonia, tuberculosis, and bronchiolitis that 
are the leading contributors to ARIs' mortality7 . Pneumonia, with a global 
burden of 5 000 childhood deaths every day, is a tangible threat that needs 
to be dealt with accordingly. 
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The incidence of ARIs in children aged less than 5 years is estimated 
to be 0.29 and 0.05 episodes per child-year in developing and 
industrialized countries, respectively, which translates into 151 million and 
5 million new episodes each year, respectively8. Most cases occur in India 
(43 million), China (21 million), Pakistan (10 million), Bangladesh, 
Indonesia and Nigeria (56 million each). Pneumonia is responsible for 
about 21% of all deaths in children aged less than 5 years, leading to 
estimate that of every 1000 children born alive, 12-20 die from pneumonia 
before their fifth birthday6. The incidence of pneumonia in developed 
countries may be as low as 3-4%, its incidence in developing countries 
range between 20-30% this difference is due to high prevalence of 
malnutrition, LBW and indoor air pollution 9. 
Etiology  
CAP can be caused by a variety of organisms (table 1)10-13. 
Identification of the causative organism would direct treatment but 
accurate, fast, affordable, and widely available diagnostic tools are still 
awaited. 
There is a current widely held belief that the causative organisms 
vary according to the age of the child, viruses being most common in 
children under 5 years old. Respiratory syncitial virus (RSV, most 
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common in the very young), adenovirus, parainfluenza virus, influenza 
virus, and more recently metapneumovirus14 virus have all been identified 
in this age group. 
 
Table.1 causative pathogen among different age groups 
Age Common Cases Less Common 
birth to 20 days 
 
 
 
 
 
 
 
 
 
3weeks to 3 months 
 
 
 
 
 
 
4 months to 5 years 
 
 
 
 
 
 
 
5yrs to adolescence  
 bacteria   
 Escherichia coli 
 Group B Streptococci 
 Listeria monocytogen 
 
 
 
 
 
 
bacteria 
Chlamydia trachomatis 
S.Pneumoniae 
viruses 
Adenovirus 
Influenza virus 
Parainfluenzavirus 1,2,3 
Respiratorysyncytialvirus.
Bacteria 
Chlamydia pneumonia 
Mycoplasma pneumoniae 
Viruses 
Adenovirus 
Influenza virus 
Para influenza virus 
Rhinovirus, RSV 
 Bacteria 
C. Pneumoniae 
M.Pneumoniae 
S.Pneumoniae 
 
 
 
bacteria  
Anaerobic Organisms  
Group D streptococci 
Haemophilus influenza 
Streptococcus pneumonia 
Urea plasma ureolyticum 
viruses 
Cytomegalo virus 
Herpes simplex. 
bacteria 
Bordetella pertusis 
H.Influenzae  
Moraxella catarrhalis 
Staph.aurius 
U.Urealyticum 
Viruses 
Cytomegalovirus 
Bacteria 
H.Influenzae1 
M.Catarrhalis. 
M.tuberculosis 
N. meningitis 
S.aureus 
Viruses 
Varicella-Zoster 
Bacteria 
H.Influenza 
Legionella  
M.tuberculosis 
S.aureus 
Viruses  
Epstein-Barr virus 
Para influenza  
Rhinovirus
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Bacterial causes are reported as being more common in older 
children. Most etiology studies in the developed world from the last 15 
years suggest that Streptococcus pneumoniae and mycoplasma account for 
most cases of bacterial pneumonia15-20; however, the number of cases 
attributable to these two organisms varies greatly between studies. The 
incidence of S pneumoniae varies from 4%21 to 8%15 to 21%22. Similar 
differences are seen for mycoplasma. 
There are studies that support a preponderance of particular 
organisms in different age groups. For example, a Finnish study23 found 
that in children younger than 5 years of age, the incidence of S 
pneumoniae infection was 8.6/1000 per year and mycoplasma 1.7/1000 per 
year. In children aged from 5–15 years, the incidence of S pneumoniae fell 
to 5.4/1000, while that of mycoplasma rose to 6.6/1000. However, the 
audit by Clark et al24 did not support this finding; in their study the mean 
age of children with mycoplasma infection was 3.5 years. Apart from S 
pneumoniae and mycoplasma, other organisms that need to be considered 
include Chlamydia trachomatis, Bordetella pertussis, Staphylococcal 
aureus, and Mycobacterium tuberculosis.  
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DIAGNOSIS 
Clinical presentation 
Children and infants may present with a number of different clinical 
symptoms and signs such as fever, cough, and tachypnoea. A minority of 
children will present with pyrexia of unknown origin and may have no 
respiratory symptoms or signs. 
The WHO has developed an algorithm25 to aid medical and non-
medical health care workers in diagnosing lower respiratory tract infection 
without radiological confirmation. This algorithm was designed for use in 
the developing countries but is still useful as a clinical tool in the UK. The 
WHO algorithm stresses the importance of tachypnoea (table 2) as an 
indicator of pneumonia. Studies from the developed world support this 
finding26,27. Palafox26 found that tachypnoea (as defined by WHO) had a 
74% sensitivity and 67% specificity for radiologically defined pneumonia. 
However, clinicians must be cautious in children who present early in the 
disease. In children who had the disease for less than three days26, 
tachypnoea had a lower sensitivity and specificity of illness. Clinicians 
must be aware that the absence of tachypnoea does not necessarily mean 
the absence of pneumonia27. 
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Tachypnoea as a sign of pneumonia must also be used with caution 
in children with co-morbid conditions such as asthma where tachypnoea is 
a sign of deterioration of the underlying condition; even when combined 
with a fever and cough it would not necessarily require the addition of an 
antibiotic. 
The signs like grunting and nasal flaring increase the chance of 
pneumonia, but their absence cannot be relied upon to rule out 
pneumonia26. Other signs that relate to the severity of the pneumonia are 
chest in-drawing, nasal flaring, and cyanosis. Other noises such as rales, 
rhonchi, or crackles alone are not sensitive or specific for the diagnosis of 
pneumonia. 
High fever in young children (aged up to 3 years) is also found to be 
a sign of pneumonia28,29. A temperature >38.5˚C is a feature of bacterial 
pneumonia2. The BTS guidelines have suggested that in children under 3 
years old a combination of fever >38.5˚C, chest recession, and respiratory 
rate of more than 50 indicates pneumonia. Breathing difficulty itself is a 
more reliable sign in older children. The absence of clinical signs is more 
helpful to a clinician than their presence. If all clinical signs are negative, 
pneumonia is unlikely. However, if signs are present, they can be used in 
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combination to guide the clinician to consider a diagnosis of pneumonia 
but do not secure a definitive diagnosis. 
Table 2      WHO defined tachypnoea 
< 2 months of age. >60 breaths/min 
2–12 months >50 breaths/min 
>12 months >40 breaths/min 
ep30 
A child with mycoplasma infection may present with symptoms 
such as wheeze and cough, therefore mycoplasma infection should be 
considered in a patient with suspected asthma not responding to treatment. 
Mycoplasma may also present with abdominal pain or chest pain. 
Abdominal pain may also be caused by bacterial pneumonia owing to 
diaphragm irritation. It is one of the differential diagnoses in a child who 
presents with fever and abdominal pain, and can present to the surgeons as 
well as to paediatricians. Pneumonia needs to be excluded in infants 
presenting with pyrexia of unknown origin or a picture of generalized 
sepsis. 
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Admission to hospital 
A child may be admitted to hospital if: 
1. they are not tolerating oral medication due to vomiting, or 
2. there are social concerns—for example, family unable to provide 
appropriate support, or 
3. They have signs or symptoms of severe breathing difficulty. 
Table 3 is a summary of recommendations2,25,30 from the BTS, WHO, 
and Paediatric Accident and Emergency Research Group guidelines to help 
clinicians to identify which children may need to be admitted to hospital.  
Table 3 Indications for admissions to hospital 
Oxygen saturation >92% in air 
RR >70/min in infants, >50/min in older children 
Signs of severe breathing difficulty;  
chest wall in-drawings, nasal flaring, grunting, apnea 
Feeding less than half normal intake 
Signs of dehydration 
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Serological diagnosis and other laboratory tests 
A variety of different laboratory tests are currently used in 
combination with clinical assessment to diagnose pneumonia. Indications 
for their use are discussed below. 
The white blood cell count, C reactive protein (CRP), and 
erythrocyte sedimentation rate (ESR) have been used as markers of 
infection, but none of them have been shown to be helpful in 
distinguishing between bacterial, viral and a mixed pneumonia31. The 
routine measurement of acute phase reactants in the child with pneumonia 
is therefore not recommended2. 
Blood cultures are routinely taken in many hospitals, but they have a 
low yield for identification of the causal organism(s)15,22. In addition they 
take 2–3 days for a positive result and so are not helpful in informing 
initial antibiotic prescribing. It is not recommended that blood cultures are 
taken in the community setting, although within the hospital setting the 
BTS guidelines still recommend that they are performed2. 
Polymerase chain reaction (PCR) enhances the identification of the 
pneumococcal organism15 and mycoplasma. PCR testing is expensive, not 
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widely available, and not rapid enough to affect initial management. The 
routine use of PCR is currently not recommended, but in the future may 
provide important evidence of specific etiology and guide treatment. 
Mycoplasma pneumonia remains difficult to diagnose clinically and 
serologically, therefore treatment is often started empirically. Cold 
agglutinins seen in mycoplasma infection have been used during the acute 
phase but have limited value since the positive predictive value is only 
70%32.The gold standard remains paired serology 14 days apart. The BTS 
guidelines do not give clear recommendations of when serological tests for 
mycoplasma should be performed since most children are treated for the 
disease empirically based on the clinician’s suspicion of the organism 
being present. Until more evidence is available it is useful for paired 
samples to be taken in children who are not responding to treatment. 
Nasopharyngeal aspirate for viral immune fluorescence and viral 
antigen detection may be useful in identifying a virus but has little effect 
on the immediate management of a patient. These tests are highly sensitive 
and help to identify RSV positive children so that they can isolated, 
thereby avoiding infection of other children on the ward. The results of this 
test are also useful for epidemiological purposes, but it is important to be 
12 
 
aware that pneumonia may have a mixed etiology and may still require 
antibiotic treatment. 
Table 4 provides a summary2,30 from the BTS and the Paediatric 
Accident and Emergency Research Group guidelines of investigations 
useful for children admitted to hospital with suspected pneumonia based 
on current evidence.    
Table 4    Useful investigations in hospital 
Blood cultures if suspected to have bacterial pneumonia 
Acute serum, and convalescent serum if no diagnosis made during acute 
illness 
Nasopharyngeal aspirate in children ,18 months 
If significant pleural fluid present, pleural aspiration   
 
Radiological diagnosis 
The chest X ray (CXR) is still considered to be the gold standard for 
diagnosing pneumonia in the developed world. However, there is poor 
concordance between radiologists about what radiological changes 
constitute pneumonia. An additional problem is the variation in reporting 
CXRs between radiologists. Davies et al 33studied the CXRs of 40 infants 
under the age of 6 months admitted with lower respiratory tract infection 
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and showed that there is variation in intra-observer and inter-observer 
agreement among radiologists. Others have confirmed this34. Consolidation 
on the CXR was most commonly identified by the radiologists and 
generally agreed to represent pneumonic change33. 
WHO has recognized the difficulties with CXR interpretation and 
developed a tool to standardize the reporting of CXR for use in 
epidemiological studies of pneumonia. This system classifies CXR as 
normal appearance, infiltrates or end stage consolidation defined as a 
‘‘significant amount of alveolar type consolidation’’. So does a normal 
CXR rule out pneumonia? There is anecdotal evidence for having 
pneumonia with a normal CXR. Fever and tachypnoea may present before 
CXR changes are seen. How this is managed will depend on the individual 
case taking into account factors such as age and length of illness. 
Can CXR be used to assess etiology? In an earlier section, the 
difficulty with serological diagnosis was highlighted. A similar difficulty 
arises in trying to use CXR to distinguish etiology. Swischuk35 found a 
90% accuracy rate overall when trying to differentiate bacterial from viral 
pneumonia. However, in this study cases were classed as being viral or 
bacterial on clinical grounds, a system which is known to be flawed. 
Bettenay36 found that there was only a 30% chance of isolating a bacterium 
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when the CXR suggested a bacterial cause using the system designed by 
Swischuk. Thus, although consolidation is reliable for diagnosing 
pneumonia, it should not be used to assume a bacterial infection. This was 
further demonstrated in an etiology study by Virkki et al37. In this study, 
etiology and radiological changes were assessed in 254 children; only 72% 
of those with alveolar infiltrates had a bacterial infection. In children with 
solely viral pneumonia 50% had alveolar changes. Looking at the group 
with interstitial changes, half had evidence of viral infection and the other 
half had bacterial infection. This has been confirmed in a systematic 
review looking at the differentiation between viral and bacterial lower 
respiratory chest infection38. 
When should CXR be performed? 
 A systematic Cochrane review38 indicates that there is no evidence 
to show that performing a CXR in ambulatory children (that is, children 
not admitted to hospital) aged over 2 months with an acute lower 
respiratory infection affects outcome and therefore it is not routinely 
necessary to perform CXR before treatment. In these children the clinician 
can use clinical signs and symptoms to direct management. 
It is unclear which clinical signs should indicate the need for CXR. 
The available studies which examine the relation between clinical signs 
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and radiological changes give different results, but with the evidence 
available39-42 the BTS2 has concluded that ‘‘it is advisable to consider a 
CXR in a child <5 years with a fever of 39˚C of unknown origin unless 
classical features of bronchiolitis are present’’. 
The contribution of CXR to management of children admitted to 
hospital with more severe symptoms is also not clear. CXRs have not been 
shown to alter management decisions or the time taken to recovery. CXRs 
are helpful when a complication such as pleural effusion is suspected, or 
pneumonia is prolonged or unresponsive to antimicrobials. 
In summary, CXR is not helpful in determining etiology and does 
not contribute to the management of ambulatory children with mild 
uncomplicated lower respiratory tract illness. CXR to diagnose pneumonia 
may be helpful in some scenarios as detailed above. Table 5 provides some 
guidance2 for clinicians as to which children would benefit from CXR. The 
guidance is not very specific because of the lack of research in this area. 
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Table 5 Indications for CXR in either primary care or hospital 
For diagnosis of child <5 years with fever of 39˚C of unknown origin 
If complication (for example, pleural effusion) suspected 
Atypical symptoms or unresponsive to treatment 
For follow up of children with lobar collapse or ongoing symptoms 
For follow up of children with lobar collapse or ongoing symptoms 
 
Treatment 
The clinician faces four problems: 
1. Whether to treat with antibiotics or not 
2. If the decision is to treat, whether to use a narrow or broad spectrum 
antibiotic 
3. Whether to administer the antibiotics via the oral or the intravenous 
route 
4. Whether admission to hospital is required. 
There has been only one study addressing the question of whether to 
treat or withhold antibiotics. Friis et al43 conducted a prospective 
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randomized controlled trial allocating children with pneumonia to 
receiving either antibiotics or placebo. No difference was seen between the 
two groups in the course of the acute disease or with the development of 
pulmonary complications. However, 15 of the 64 children in the placebo 
group went on to receive antibiotics. On the basis of this study the BTS 
guidelines2 suggest that young children (no age range given in the 
guidelines) presenting with mild symptoms of lower respiratory tract 
infection need not be treated with antibiotics. For all other children 
antibiotic treatment is warranted, but which antibiotic and by which route 
is by no means clear. Unfortunately, there exists a paucity of well 
conducted adequately powered randomized controlled trials comparing the 
effectiveness of different classes of antimicrobial agents in paediatric 
pneumonia. 
Most children will be able to be treated using oral antibiotics in the 
community. Inpatient treatment is required if: 
1. There are social concerns about the care of the child or concerns that 
the child will be given the antibiotics at home 
2. The child is vomiting and either requires a trial of oral antibiotics in 
hospital or intravenous antibiotics if oral preparations are not 
tolerated 
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3. The child has signs of severe disease and requires supportive 
therapy—for example, oxygen 
4. The child has severe disease and requires intravenous antibiotics 
5. The child needs to be admitted to intensive care or high dependency. 
Which antibiotic? 
The choice of antibiotic is largely empirical, based on the most 
likely organism from etiology studies while also considering the age of the 
child. The most common cause of bacterial pneumonia is S pneumoniae. 
Resistance of S pneumoniae to penicillin is increasing but overall remains 
low. The BTS guidelines therefore suggest oral amoxicillin as first line 
treatment in children < 5 years, with co-amoxiclav, cefaclor, erythromycin, 
clarithromycin, and azithromycin as alternatives. Recommendations for the 
treatment of children >5 years are less clear. The true incidence of 
mycoplasma, even in the younger age group, is not known and varies 
widely in etiology studies, from 2% to 39%44. Therefore the use of 
macrolides either as first line treatment alone or in addition to penicillin 
poses a much more difficult question for the clinician. Studies comparing 
the use of macrolides with other groups of antibiotics as first line treatment 
have not been able to provide clear recommendations45-47. A clinical trial 
comparing antibiotic treatment options is required. 
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Route of administration 
There have been no randomized controlled trials to investigate 
whether children admitted to hospital should be treated with oral or 
intravenous (IV) antibiotics. The BTS guidelines suggest that IV 
antibiotics should be reserved for children with severe symptoms or signs 
or those who are unable to tolerate oral antibiotics. In practice, however, 
many children deemed unwell enough to be admitted to hospital (for 
example, who are vomiting or requiring some oxygen) are treated with iv 
antibiotics irrespective of the severity of their signs or symptoms. The BTS 
guidelines initially stated that antibiotics administered orally are safe and 
effective for children presenting with CAP. Following appraisal by the 
quality of practice committee at the Royal College of Pediatrics and Child 
Health, this statement was amended to ‘‘amoxicillin administered orally is 
effective for children >6 months who are well enough to be treated without 
hospital admission’’. This is based on a trial comparing the efficacy of one 
dose of intramuscular penicillin to oral amoxicillin given to children in 
accident and emergency who were well enough to be discharged home48. 
Results of a multicentre randomized controlled trial comparing oral and IV 
treatment for children who require admission to hospital should be 
available later this year. 
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Length of treatment 
There is currently little research to indicate the most appropriate 
length of time that a child with CAP should be treated with antibiotics. 
Oral antibiotics are routinely prescribed for 5–7 days, but treatment 
duration is increased to 10 days for severe infections (depending on which 
antibiotic is used). This practice is not based on clinical research and 
depends on the individual clinician. A multicentre randomized controlled 
trial has been completed in India49, but this study only compared children 
with ‘‘non severe’’ pneumonia in the paediatric outpatient department and 
cases of pneumonia were based on a clinical diagnosis and not confirmed 
by CXR. 
There are no randomized controlled trials in children addressing the 
issue about when to switch from intravenous antibiotics to oral antibiotics. 
If the child is clearly improving the clinician makes a judgment that it is 
safe to transfer to oral antibiotics2. Most often this is after 24 hours of 
intravenous treatment, when the temperature falls and symptoms of 
breathing difficulty are resolving. 
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Complications 
Most children with CAP improve without any sequelae. However, a 
small proportion develops complications which need treating. Table 6 
provides a list of complications that may be encountered in children 
presenting with CAP.  
Table 6    Complications of CAP 
Treatment failure caused by antibiotic resistance 
Pleural effusion and empyema 
Lung abscess Septicemia 
Metastatic infection—for example, osteomyelitis or septic arthritis 
 
Follow up 
Once the patient has been discharged from hospital, some clinicians 
arrange follow up X rays at 6–8 weeks. The value of this has been 
questioned and unless the child continues to be symptomatic or has lobar 
collapse or ‘‘round pneumonia’’, it is not recommended50,51 
Integrated management of neonatal and childhood illness (IMNCI)52 
India being one of the countries with highest number of pneumonia 
deaths it is essential to optimize criteria for triage; early referral; 
hospitalization and commence treatment. This has been aided by the 
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IMNCI strategy that simplifies the classification of illness severity for 
major acute childhood illness including pneumonia. IMNCI was first 
developed in 1992 by UNICEF and the World Health Organization (WHO) 
with the aim of prevention, or early detection and treatment of the leading 
childhood killers 
The IMNCI initiative adopted a broad, cross-cutting approach 
recognizing that in most cases; more than one underlying cause contributes 
to the illness of the child. A great deal has been learned from disease-
specific control programs over the past 15 years. IMNCI attempts to 
combine the lessons learned into an effective approach for managing the 
sick child.  
While the management of childhood illness focuses on treatment, it 
also provides the opportunity to emphasize prevention of illness through 
education on the importance of immunization, micronutrient 
supplementation, and improved nutrition – especially oral rehydration 
therapy (ORT), breastfeeding and infant feeding. IMNCI seeks to reduce 
childhood mortality and morbidity by improving family and community 
practices for the home management of illness, and improving case 
management of skills of health workers in the wider health system.  
Key factors in the child’s immediate environment – nutrition, 
hygiene, immunizations - are as important as medical treatment in 
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improving health.  IMNCI is the umbrella through which all community 
health interventions can be delivered to the child.  
Process of IMNCI52 
Integrated case management relies on case detection using simple 
clinical signs and research-based treatment. As few clinical signs as 
possible are used. The IMNCI process (see figure 1) includes three basic 
steps for every health topic included: 
Assess a child through questions and observation. First the 
Community Health Worker checks for the presence of danger signs. 
Henceforth, s/he “evaluates” the presence of main symptoms related to 
cough/difficult breathing, diarrhea/dehydration, malaria, fever, ear 
infections and malnutrition. The following step includes the assessment of 
immunization status and vitamin A supplementation. 
Classify the condition of the child using a color-coded triage 
system. Thus, red color indicates urgent need for referral; the yellow 
color indicates referral, and green color, home-management and 
follow-up. 
Identify specific treatments for the child. Each treatment is 
determined in accordance to the color-coded classification and explained in 
detail in the clinical guidelines. 
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Figure 1.  Process of the management of cases in the IMNCI strategy 
for children of 2 months to 5 years old.  
Check for DANGER SIGNS 
• Convulsions 
• Lethargy/ unconsciousness 
• Inability to drink / breastfeed 
• Vomiting 
 
Assess MAIN SYMPTOMS 
• Cough / difficulty breathing 
• Diarrhea 
• Malnutrition 
• Other problems 
 
Assess IMMUNIZATION status and 
vitamin A supplementation 
            
Classify Conditions and Identify 
Treatment Actions 
 
 
 
 
Urgent Referral  Referral        Home Treatment  
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For cough or difficult breathing in a child between 2 months to 5 years 
IMNCI assess, classify and decide treatment based on following table. 
 
 
SIGNS 
 CLASSIFY AS 
IDENTIFY  TREATMENT 
(Urgent pre-referral treatments are in bold print) 
 
Any general 
danger sign 
or 
 Chest in 
drawing or 
Strider in 
calm child. 
 
 
 
 
       SEVERE 
PNEUMONIA 
OR VERY 
SEVERE 
DISEASE  
 
 
 
 
 
 
Give first dose of injectable chloramphenicol           
(If not possible give oral amoxicillin). 
 
Refer URGENTLY to hospital. #  
Fast 
breathing 
 
PNEUMONIA 
  
 
 
 
Give Cotrimoxazole for 5 days. 
 
Soothe the throat and relieve the cough with  
a safe remedy if child is 6 months or older. 
 
Advise mother when to return immediately. 
 
Follow-up in 2 days. 
  
No signs of 
pneumonia 
Or very 
severe 
disease. 
NO 
PNEUMONIA:
COUGH OR 
COLD 
If coughing more than 30 days, refer for 
assessment. 
 
Soothe the throat and relieve the cough with a safe 
home remedy if child is 6 months or older.  
 
Advise mother when to return immediately. 
 
Follow-up in 5 days if not improving 
 
 
Acute illness observation scale (AIOS) 
IMNCI strategy will be more effective in managing pneumonia 
when supplemented by an illness severity scoring system delivered in the 
26 
 
context to primary care setting that can quantity quickly the severity of 
illness at all stages from onset to recovery. In this regard use of AIOS- a 
genetic illness severity scale developed by P.L. McCarthy –represent a 
destructive paradigm drawing on simple observations(based on toxic 
appearance) instead of complex symptomatology, aiming for wholeness 
rather than details and encompassing the entire not just the ends of 
sickness continuum. AIOS is a three point scale for six ordinal variables 
and total score range from 6-30. It is a validated clinical index of 
quantifying risk of serious bacterial infection in children 36 months or 
younger presenting with febrile illnesses. AIOS focuses on six easily 
observed factors that, taken together, are a sensitive, indicator of serious 
illness children. Incidence of serious bacterial infection is less than 2-3% if 
a febrile child scores 10 or less; 26% if scores are between 11-15 and 92% 
if AIOS score is 16 or above. 
Acute illness observation scale53: composition and score description 
Quality of Cry  
1. Strong cry with normal tone or contented and not crying  
2. Whimpering or sobbing  
3. Weak cry, moaning, or high-pitched cry  
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Reaction to Parental Stimulation  
1.  Cries briefly and then stops, or is contented and not crying  
2. Cries off and on  
3. Cries continually or hardly responds  
State Variation  
1. If awake, stays awake, or if asleep and then stimulated, awakens 
quickly  
2. Closes eyes briefly when awake, or awakens with prolonged 
stimulation  
3. Falls asleep or will not arouse  
Color  
1. Pink  
2. Pale extremities or acrocyanosis  
3. Pale, cyanotic, mottled or ashen  
Hydration  
1. Normal skin and eyes, moist mucous membranes  
2. Normal skin and eyes, slightly dry mouth  
3. Doughy or tented skin, dry mucous membranes and/or sunken eyes 
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Response (Talk, Smile) to Social Overtures, Over 2 Months  
1. Smiles or alerts  
2. Smiles briefly or alerts briefly  
3. No smile, anxious face, dull expression, or does not alert  
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AIM OF STUDY 
 
To validate AIOS in predicting illness severity and clinical outcome 
of community acquired pneumonia 
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LITERATURE REVIEW 
AIOS in predicting illness severity 
1. In order to define valid and reliable observation data for judgment 
prior to history and physical examination McCarthy PL et al54 did a study 
between Nov 1, 1980 and March 1, 1981, using a 14 scaled item which 
were scored simultaneously by attending physician, residents, and nurses 
prior to history and physical examination on 312 febrile children aged<=24 
months seen consecutively in a Primary Care Center Emergency Room and 
in one private practice. Of these 312 children, 37 had serious illness. 
Multiple regression analysis based on patients seen by at least one 
attending physician in Primary Care Center revealed six items (quality of 
cry, reaction to parents, state variation, color, hydration status, and 
response to social overtures) that were significant and independent 
predictors of serious illness (multiple R = 0.63). The observed agreement 
between for these six items between two attending physicians who saw one 
third of the patients ranged from 88% to 97%. The chance corrected 
agreement level (ḵW) for these six items were with one exception, 
clinically significant (ḵW=0.47 to 0.73). A discriminate function analysis 
revealed that these six items when used together had a specificity of 88% 
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and sensitivity of 77% for serious illness. Individual scores for each of the 
six key items were added to yield a total score for each patient. Only 2.7% 
of patients with a scores ≤ 10 had a serious illness, 92.3% with a score ≥16 
had a serious illness. The sensitivity of the six-item model for serious 
illness when combined with history and physical examination was 92%. In 
the population studied, this predictive model, when used prior and physical 
examination, was reliable predictive, specific, and sensitive for serious 
illness in febrile children. It was most sensitive when combined with 
history and physical examination. The model wifi need to be validated on a 
new population of patients. 
2. To determine if observational assessment performed in a systematic 
manner adds to the efficacy of the traditional history and physical 
examination in detecting serious illness in febrile children, and to 
determine the sensitivity of the combined evaluation, McCarthy PL et al55 
in 1982 studied consecutive patients < 24 months of age seen for 
evaluation of fever. The study showed that combined AIOS, history, and 
physical examination had a higher sensitivity and re correlation for serious 
illness than did the traditional history and physical examination. Three 
children with serious illness, all of whom had no abnormalities on history 
and physical examination, were identified only by use of AIOS. 
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3. In the perspective of IMNCI Strategy and recent evidence favoring 
use of oral antibiotics in severe pneumonia with an objective of validating 
AIOS in severe pneumonia a study was done at a civil hospital in remote 
hilly region of shimla district of Himachal Pradesh by Bharathi Bhavaneet 
et al56 which showed that children scoring abnormally on AIOS (>10) had 
significantly higher frequency of severe tachypnea (P>0.01), marked 
recession (P>05), and grunting (P-0.01) while frequency of inability to 
drink reached statistical significance (P<0.05) only for children who scored 
16 on AIOS. 
AIOS in determining clinical outcome 
The study56 done in shimla district of Himachal Pradesh showed that 
higher the scores on AIOS, longer it took for tachypnea to decrease 
(P<01), as well as subside (P-01) and hospital stay was also prolonged 
(P<01). Although not significant, scores also tended to positively correlate 
with time taken for fever to settle (P<10) 
AIOS correlation between physician and mothers 
A study was done by Paul L. McCarthy MD57, Domenic V et al from 
The Departments of Pediatrics and psychiatry, Yale University School of 
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Medicine in 1991. The purpose of this study was to investigate to what 
extent selected adverse demographic, clinical, and psychosocial data 
measured at the 2-week well child visit could predict poorer reliability of 
mothers' judgments during acute illness episodes over the next 32 months. 
The study was a randomized trial of the Acute Illness Observation Scales 
(AIOS); 369 mothers participated, 183 in the intervention group using the 
Acute Illness Observation Scales and 186 in the control group using a 
three-point global assessment scale. There were 704 acute illnesses judged 
simultaneously and independently by mothers and pediatricians. Standard 
Pearson r correlations were performed between the independent variables, 
taken singly and in all possible combinations, and the dependent variable, 
reliability of mothers' judgments as measured by weighted kappa (kw). 
Group assignment was entered as an independent variable. Analyses were 
performed separately for all first, second, and third acute illness visits to 
control for any "practice effect" (analysis 1). To control for consistency of 
observers, the first, second, and third visits of mothers with three visits 
were also analyzed (analysis 2). Depending on the visit number, adverse 
demographic, clinical, and psychosocial characteristics did correlate with 
poorer reliability independent of group assignment. The correlations 
ranged from small (analysis 1, first visit, multiple variable r2 = 4%) to large 
(analysis 2, second visit, multiple variable r2 = 29%). Controlling for both 
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visit number and consistency of observers vs visit number alone (analysis 2 
vs analysis 1) increased multivariate correlations to kW. The results 
support the untoward impact that adverse demographic, clinical, and 
psychosocial factors have on mothers' clinical judgment. These data may 
assist pediatricians in identifying parents who might benefit from more 
intensive teaching and support about acute illness episodes in their children 
Spectrum of clinical features and management of community acquired 
pneumonia 
To describe the spectrum of clinical features and management of 
community acquired pneumonia in the UK a study was done by Clark JE, 
Hammal D, Spencer D, Hampton F58 from the Department of Paediatric 
Infectious Disease, Newcastle General Hospital, Newcastle, UK. They 
prospectively recorded clinical details for all children with possible 
pneumonia and chest X ray (CXR) changes in 13 hospitals in the North of 
England between 2001 and 2002. 89% of 711 children presenting to 
hospital with pneumonia were admitted; 96% received antibiotics, 70% 
intravenously. 20% had lobar CXR changes, 3% empyema and 4% 
required intensive care. Respiratory rate (RR), hypoxia and dyspnoea all 
correlated with each other and prompted appropriate interventions. 
Admission in children, not infants, was independently associated with RR, 
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oxygen saturation, lobar CXR changes and pyrexia. Neither C-reactive 
protein, lobar CXR changes or pyrexia were associated with severity. 
Children over 1 year old with perihilar CXR changes more often had 
severe disease (p = 0.001). Initial intravenous antibiotics were associated 
with lobar CXR changes in infants and children and with dyspnoea, 
pyrexia and pleural effusion in children. The presence of pleural effusion 
increased duration of antibiotic treatment (p<0.001). Cefuroxime was the 
most often used intravenous antibiotic in 61%. Oral antibiotics included a 
penicillin in 258 (46%), a macrolide in 192 (34%) and a cephalosporin in 
117 (21%). Infants stayed significantly longer (p<0.001) as did children 
with severe disease (p<0.01), effusions (p = 0.005) or lobar CXR changes 
(p< or =0.001). 
Hypoxemia in pneumonia. 
1. Since oxygen has to be given to most children in developing 
countries on the basis of clinical signs without performing blood gas 
analyses, possible clinical predictors of hypoxemia were studied by M. 
Weber, S. Usen, A. Palmer, S. Jaffar59, and E Mulholland Medical 
Research Council Laboratories, Fajara, The Gambia in 1996. Sixty nine 
children between the ages of 2 months and 5 years admitted to hospital 
with acute lower respiratory tract infection and an oxygen saturation 
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(SaO2) < 90% were compared with 67 children matched for age and 
diagnosis from the same referral hospital with an SaO2 of 90% or above 
(control group 1), and 44unreferred children admitted to a secondary care 
hospital with acute lower respiratory infection (control group 2). Using 
multiple logistic regression analysis, sleepiness, arousal, quality of cry, 
cyanosis, head nodding, decreased air entry, nasal flaring, and upper arm 
circumference were found to be independent predictors of hypoxemia on 
comparison of the cases with control group 1.Using a simple model of 
cyanosis or head nodding or not crying, the sensitivity to predict 
hypoxemia was 59%, and the specificity 94% and 93% compared to 
control groups 1 and 2, respectively; 80% of the children with an SaO2 < 
80% were identified by the combination of these signs. Over half of the 
children with hypoxemia could be identified with a combination of three 
signs: extreme respiratory distress, cyanosis, and severely compromised 
general status. Further prospective validation of this model with other 
datasets is warranted. No other signs improved the sensitivity without 
compromising specificity. If a higher sensitivity is required, pulse oximetry 
has to be used. 
2. Another study was done by Sudha Basnet, Ramesh Kant Adhikari 
and Chitra Kumar Gurung60  from Department of Pediatrics, Department of 
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Community Medicine and Family Health, EPC 376, Kathmandu, Nepal 
with an objective to assess the prevalence of hypoxemia in children, 2 
months to 5 years of age, with pneumonia and to identify its clinical 
predictors Patients were categorized into groups: cough and cold, 
pneumonia, severe pneumonia and very severe pneumonia. Hypoxemia 
was defined as an arterial oxygen saturation of <90% recorded by a 
portable pulse ox meter. The prevalence of hypoxemia (SpO2 of <90%) in 
150 children with pneumonia was 38.7%. Of them 100% of very severe 
pneumonia, 80% of severe and 17% of pneumonia patients were hypoxic. 
Number of infants with respiratory illness (p value=0.03) and hypoxemia 
(Odds ratio=2.21, 95% Cl 1.03, 4.76) was significantly higher. Clinical 
predictors significantly associated with hypoxemia on univariate analysis 
were lethargy, grunting, nasal flaring, cyanosis, and complaint of inability 
to breastfeed/drink. Chest in drawing with 68.9% sensitivity and 82.6% 
specificity was the best predictor of hypoxemia.  
Antibiotics in pneumonia61 
1. The studies includes randomized controlled trials (RCTs) and quasi – 
RCTs comparing the two ways of giving antibiotics in the treatment of 
pneumonia. 
2. Only three studies met all criteria for eligibility and 29 were rejected. 
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3. Campbell 1988 compared oral cotrimoxazole versus intramuscular 
penicillin followed by an oral antibiotic in 134 children.  There was 
similar recovery in both groups at follow up. 
4. APPIS Group 2004 evaluated 1702 patients, comparing oral 
amoxicillin, against intravenous penicillin for two days. They showed 
equivalence in effectiveness and safety in both treatments. 
5. Oral therapy appears to be an effective and safe alternative to 
parenteral antibiotics in hospitalized children with severe pneumonia 
who do not have any serious signs or symptoms  
6. There is currently insufficient evidence to determine the relative 
benefits and harms of oral antibiotics in children with severe 
pneumonia if serious signs and symptoms are present or in children 
with severe pneumonia associated with bacterial conformation or lobar 
consolidation of chest X-ray. 
Illness severity in community acquired pneumonia 
For assessing illness severity in CAP in children there are no studies 
available in the literature, but for adults there are scoring systems for the 
same. For adults The Pneumonia Severity Index has been useful in 
assessing community-acquired pneumonia (CAP) and will continue to be. 
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However, two other CAP evaluation tools, the CURB-65 score and its 
relative the CRB-65 score, were recently validated.1 
CURB-65, as many pulmonologists know, is an acronym for 
Confusion, Urea (greater than 7 mmolڄL-1), Respiratory rate (30ڄmin-1 or 
greater), low Blood pressure, and an age of 65 or older. "The current study 
demonstrates a significant correlation between the CURB-65 score and the 
risk of 30-day mortality, need for mechanical ventilation, and rate of 
hospital admission," related the authors. "Among hospitalized patients, the 
CURB-65 score was significantly associated with duration of hospital 
stay." 
The results were similar for the even simpler CRB-65 score, the 
authors also reported; they pointed out that a urea measurement was 
omitted from that score.  
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STUDY JUSTIFICATION 
Gaining an objective understanding of well being of a child with 
pneumonia is essential to optimize criteria for triage, early referral, 
hospitalization and deciding on initial therapeutic modalities in less 
developed countries. This has been aided by IMCI strategy that simplifies 
the classification of illness severity for major acute childhood illness 
including pneumonia.  
Several studies has been conducted in India to measure the 
effectiveness of IMCI and showed IMCI to be an effective strategy for 
case management in acute childhood illness.  IMCI strategy will be more 
effective in managing pneumonia when supplemented by an illness 
severity scoring system delivered in the context to primary care setting that 
can quantity quickly the severity of illness at all stages from onset to 
recovery. This need has been augmented by the recent evidence favoring 
oral antibiotics in treatment of severe community acquired pneumonia.  
An objective and graded appraisal of “Clinical appearance” easily 
ascertained by primary care givers can be instrumental in influencing the 
subsequent decision. In this regard use of AIOS- a genetic illness severity 
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scale developed by P.L.  McCarthy –represent a destructive paradigm 
drawing on simple observations. AIOS focuses on six easily observed 
factors that, taken together, are a sensitive, indicator of serious illness in 
children. 
All the three components of care envisaged in IMCI strategy can be 
upgraded by the use of AIOS. Firstly, the evidence based syndromic 
approach lays significant emphasis on evaluating the severity of child’s 
condition by primary care workers who usually misclassify symptoms with 
overlapping causes or for which a single diagnosis using earlier vertical 
disease WHO algorithm, AIOS seems to fulfill this role in simple and 
objective manner. In a series of articles beginning in 1980  McCarthy et al 
ad already demonstrated the utility of AIO children who have the most 
toxic illness and those who have serious illness (e.g. pneumonia, UTI, 
meningitis, severe gastroenteritis, a focal complication etc.). AIOS offers 
an explicit, objective, and actionable easily implemented in real world 
practice. 
Second, the in hospital curative services also can be rationed by use 
of AIOS which might safely increase the proportion of children with 
severe community acquired pneumonia that can be treated as outpatient 
with oral antibiotics 
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Lastly AIOS can boost skills of mother to identify sickness of a 
child at home. In this regard, a randomized trial aimed at educating parents 
about the use of AIOS had demonstrated that its use results in more 
reliable parent judgment about well being of children during acute illness.  
Many studies have been done to demonstrate the utility of AIOS in 
detecting serious illness in febrile children. Studies criticizing AIOS were 
mainly restricted to babies below 8 weeks of age and those with occult 
bacterimia in non-toxic children. There is only one study done in Himachal 
Pradesh, India showing utility of AIOS in severe pneumonia. So there is a 
need to do such type of studies in a larger population in southern parts of 
the country like Tamil Nadu  
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METHODOLOGY 
Study design                                         
Descriptive study of a cohort of children 
Study period                                    
September 2007- September2009                                    
Study population                            
Children aged 2 to 59 months  
Study setting                               
Institute of Child health and Hospital for Children, Madras 
Medical College, Egmore, Chennai, Tamilnadu, a tertiary care hospital 
Sample size 
Proportion of children with severe illness (AIOS>10) =20% With 
precision 5% and alpha 5% sample size  is calculated as 246. 
Inclusion criteria 
Children between 2 months –59 months presenting with Fever less 
than 3 days with cough or difficult breathing with any of the following: 
1. Fast breathing 
2 Months –12 months        >50/mt 
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12 Months –5 years            >40/mt 
2 Chest in drawing 
3 Strider in calm child 
4 grunting 
5 Lethargy 
6 Convulsion 
7 Inability to drink 
Exclusion criteria 
1. Duration of illness >2 weeks 
2. Respiratory distress with prominent wheezing 
Procedure /maneuver 
1. Children between 2 months –59 months coming to OP with 
suspected pneumonia, if satisfying the inclusion criteria were 
enrolled into the study group and admitted or given treatment as 
OPD based on illness severity as assessed by IMNCI classification 
or as the physician decides. 
2. Get parental consent. 
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3. AIOS scoring is done on each subject on day 1, day 2, day 5 by two 
persons simultaneously in a reasonably quite state. 
4. Pulse oxy meter reading of each patient is recorded. 
5. Respiratory parameters and vital signs as in data collection form are 
documented 
6. Chest X ray, complete blood count, blood culture and urine culture   
were done with in 24 hrs of admission. 
7. Chest X ray was interpreted by a radiologist who was blinded about 
the study based on WHO guide lines for interpretation of X rays in 
paediatric pneumonia 
8. Treatment, investigations and the disease course as per data 
collection form are documented. 
9. Follow up until discharge or death 
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RESULTS 
 
 248 children who met with inclusion criteria were enrolled in to the 
study. Statistical analysis was done using computerized soft ware and 
results are presented as follows 
a) General characteristics 
1. Demographic characteristics 
2. Clinical features 
3. Investigations 
4. Treatment and course of the illness 
b) AIOS and its clinimetrics 
1. Inter observer variability 
2. Score distribution in study population 
3. Individual item analysis 
4. Inter item correlation 
5. Construct validity  
6. Concurrent validity 
7. Correlation with physical signs 
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8. Correlation with pulse oxymetre reading 
9. Correlation with investigations 
10. Correlation with therapeutic decision 
c) Comparison of AIOS with IMNCI 
1. Assessment of illness severity 
2. Prediction of clinical outcome 
a) General characteristics 
1. Demographic characteristics 
• Age and sex: 
The age in the study group ranged from 2months to 59 months 
(mean, 13.38 months; SD=11.2); and infants (2-12 months) (57.3%) being 
most affected. Among the 248 children 159 (64.1%) were males and the 
remaining being females with a male to female ratio of 1.7:1 
Table.1 age and sex distribution 
 n % 
age 2-12 months 142 57.3 
12-36 months 95 38.3 
>36 months 11 4.4 
sex male 159 64.1 
female 89 35.9 
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•  Nutritional status 
Majority of children, 47.2% (117/248) were below 3rd centile    as 
per WHO weight for age chart while 0.8% was above 97th percentile 
 
Table.2 weight for age percentile distribution 
Weight for age centiles n % 
<3rd 117 47.2 
3-15th 59 23.8 
15-50th 42 16.9 
50-85th 27 10.6 
85-97th 1 0.4 
>97th 2 0.8 
 
2. clinical features 
• Symptoms 
All the children presented with complaints of fever and cough while 
history of rapid and difficult breathing was obtained in 98% of cases. The 
mean duration and standard deviation of most common presenting 
complaints are given below 
Table.3 common symptoms and duration 
Symptoms Mean duration(days) SD 
fever 2.44 1.44 
cough 2.84 1.60 
breathlessness 1.66 1.25 
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Regarding danger symptoms, majority had lethargy (25%) while 
convulsion (4%) and grunt (5.6%) was least common. 
Table.4 danger signs in study population 
symptom n % 
convulsion 10 4 
Inability to drink 37 14.9 
lethargy 62 25 
grunt 14 5.6 
 
• Signs 
Vital signs like respiratory rate had a mean of 54.3(SD-9.9) while 
temperature and heart rate had a mean of 37.9 and 134.2 respectively. 
 
Table.5 vital signs distribution 
 
Signs Mean SD 
respiratory rate/mt 54.31 9.98 
Temperature(0C) 37.93 0.66 
Heart rate/mt 134.19 24.53 
Systolic BP(mmHg) 93.93 9.73 
Diastolic BP(mmHg) 56.92 8.23 
 
Regarding other respiratory morbidity signs majority had a 
respiratory rate between 51-60(48.38%) and retraction was mild-moderate 
in 53.65% and severe in 32.6%. percentage of children with 
grunting(6.4%) and cyanosis (2.4%) was very less, like wise was those 
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with abnormal capillary refill time(12.1%). Frequency of other respiratory 
signs in the affected children is shown in the following table 
 
Table.6 respiratory morbidity distribution 
 
Signs Total % 
Respiratory rate/mt 40 -50 78 31.4 
51 -60 120 48.38 
>60 50 20.16 
Intercostal recession 111 44.75 
Sub costal recession  
  
Mild-moderate 133 53.6 
severe 81 32.66 
Grunt  16 6.4 
Cyanosis  6 2.4 
Lethargy 65 26.2 
Convulsion 10 4 
inability to drink 37 14.9 
Abnormal Capillary refill time (>2 sec) 30 12.1 
 Decreased Breath sounds  11 4.5 
Bronchial breathing  14 5.6 
Crepitations  225 90.7 
Wheeze   96 38.7 
Vocal resonance  
  
Decreased 6 2.4 
increased 6 2.4 
 
3. Investigations 
• Pulse oxymetry 
Pulse oxymetre recording was taken in all children on days 1, 2 and 
5. A reading below 85%, which is associated with central cyanosis, was 
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observed in 5.6% (14/248) of cases. Spo2 recording of >92 was seen in 
54.4% (135/248) and the remaining being in between. The average pulse 
oxymetre value on day 1 in the study sample was 92.9(SD-5.10) 
 
Table.7 SpO2 reading in study population 
 
SpO2(%) N % 
<85 14 5.6 
85-92 99 39.9 
>92 135 54.4 
total 248 100 
 
• Chest X ray 
Chest X-ray evaluation was done in all patients at admission. 
Normal CXR finding were present in 46% (114/248) and remaining 54% 
(134/248) had significant abnormalities. Among the X-ray abnormalities 
end point consolidation (include dense opacity that may be a fluffy 
consolidation of a portion or whole of a lobe or of the entire lung, often 
containing air bronchogram and sometimes associated with pleural 
effusion) was seen in 39.8% while other non end point infiltrates (defined 
as linear and patchy densities featuring peribronchial thickening and 
multiple areas of atelectasis) 
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Table.8 chest X ray findings in study population 
 
investigation n % 
CXR abnormal 134 54 
normal 114 46 
finding End point 
consolidation 
53 39.8 
infiltrates 80 60.2 
 
• Other investigations 
Among other investigations, leucocytosis was seen in 13.7% 
(34/248), a positive urine culture in 12.1% (30/248) and a positive blood 
culture in 13.7% (34/248) of cases. 
Table.9 blood and urine investigations in study population 
Investigation n % 
Leucocytosis  34 13.7 
 Positive Blood culture 34 13.7 
 Positive Urine culture 30 12.1 
 
 
4. Treatment and course of the illness 
During their management 8.5% (21/248)of children were so severely 
affected that they needed normal saline boluses to correct the shock and 
7.7%(19/248)needed ionotropic support with dopamine or dobutamine. 
Airway intubation was needed in2.8% (7/248) of cases either for 
respiratory failure or shock management. Oxygen was administered for 
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32.3% (80) of cases in view of severe respiratory distress or cyanosis. 28.6 
%( 71/248) of children required maintenance i.v fluids because of severe 
respiratory distress and/or dehydration. Parenteral antibiotics were 
administered to 50.4% (125/248) patients while remaining were treated 
with oral antimicrobials. Presence of wheeze necessitated salbutamol 
nebulization in 25.4% (63/248) of cases. During the hospital stay 9.7% 
(24/248) developed complications either in the form of shock, empyema or 
pyopneumothorax. 5 children (2%) expired even after intensive care 
management.   The mean duration of hospital stay (±SD) was 4.58(±4.94) 
days. 
 
Table.10 treatment and course of the illness 
 
Treatment and course of illness n % 
antibiotic oral 123 49.6 
Intra venous 125 50.4
 IV fluids  71 28.6
 Received Fluid bolus 21 8.5 
 inotropic support 19 7.7 
 oxygen 80 32.3
ventilation 7 2.8 
nebulisation 63 24.4
Intercostal drainage 9 3.6 
decortications 3 1.2 
complication Septic shock 16 6.5 
empyema 5 2.0 
Pyopneumo thorax 3 1.2 
Hospital stay <5 days 191 77.0
6-14 days 42 16.9
>14 days 15 6.0 
Final outcome discharged 245 98.0
died 5 2.0 
54 
 
b) AIOS and its clinimetrics 
Acute illness observation scale (AIOS) is a generic illness severity 
scale developed by P.L. McCarthy. AIOS is a three point scale for six 
ordinal variables and total score range from 6-30. The composition and 
scoring pattern of AIOS scale with its clinical significance are presented in 
table 
Table.11: Acute illness observation scale: composition, score 
description  
Scale used Acute illness observation scale 
Items included Quality of cry
Response to parent stimulation 
State variation 
Color 
Hydration 
Response to social overtures 
Score interpretation Each item scored as normal(=1) 
Moderate(=3)and severe  
Impairment(=5)
Total score 6= best score
30= worst physical score 
Chance of serious illness Score≤10 : 2-3%
Score 11-15 : 26% 
Score ≥16 : 92%
 
 
1. Inter observer variability  
Inter observer variability in AIOS scoring simultaneously between 2 
observers was analyzed using Karl Pearson coefficient and was found be 
having very good positive correlation. For further analysis first 
investigator’s observations were taken in to account. 
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Table.12 inter observer correlation 
 
correlation 
Karl Pearson 
correlation 
coefficient 
interpretation 
Day 1 Inter observer R=0.98 Very good correlation 
Day 2 Inter observer R= 0.85 Very good correlation 
Day 5 Inter observer R=0.84 Very good correlation 
 
2.  Score distribution in study population  
40% of children with community acquired pneumonia scored 
abnormally (AIOS>10) at initial evaluation. Mean score for AIOS 
12.32(SD-6.12) clearly signifies the seriousness of all children enrolled in 
the study. The frequencies of abnormal AIOS scores as well as mean total 
scores for different age groups are depicted below 
Table.13 score distribution in study population 
age 
AIOS on day 1 
≤10 11-15 ≥16 
n % n % n % 
2-12 months 77 54.2 27 19 38 26.8 
12- 36 m0nths 65 68.4 14 14.7 16 16.8 
>36 months 7 63.6 0  4 36.4 
                                 χ2=7.68 P=0.16  
 
3. Individual item analysis 
In the individual item analysis of AIOS, 89.3% and 80.2% of 
affected children scored normally for the variables “color” and “hydration 
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status” respectively. In contrast majority of children showed worst score in 
the variable “response to social overtures. For each of the variable the 
percentage of normal score and abnormal score are given below 
Table.14 score distribution of each items 
item normal score(=1)%(n) 
Abnormal 
score(=3or5) %(n) 
Quality of cry 58.9%(146) 41.1%(102) 
Response to parent stimulation 38.7%(96) 61.3%(152) 
State variation 66.5%(165) 33.5%(83) 
color 89.3%(223) 10.7(25) 
hydration 80.2%(199) 19.8%(49) 
Response to social overtures 16.9%(42) 83.1%(206) 
 
4. Inter item correlation 
Scales were assessed for their inter item correlation and overall 
Cronbach’s α. Cronbach’s α for AIOS was 0.91(an alpha of 0.70 is the 
minimum desirable level) indicating the homogeneity of scale variable in 
assessing illness severity in our study sample. Over all, the individual item 
analysis of AIOS revealed either similar or decreased values for α if item 
deleted, indicating that each item added unique information to total score. 
 
Table.15    cronbach’s alpha of inter item correlation 
Cronbach’s alpha (α) 0.91 
Children with best score      n, (%) 32, (12.9%)
Children with worst score n,(%) 1, (0.4%) 
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5. Construct validity 
Total score on AIOS showed good correlation (Pearson) with 
selected clinical characteristics’ at admission like grade of fever (p<.001), 
heart rate (p<0.001), respiratory rate (p<0.001). 
Table.16 Karl Pearson correlation of AIOS with selected clinical parameters 
 
variable Karl Pearson correlation P value interpretation 
Temperature R=0.63 P=0.001 Good correlation 
Respiratory rate R=0.64 P=0.001 Good correlation 
Heart rate R=0.64 P=0.001 Good correlation 
 
6. Concurrent validity  
Relating children’s score against their radiologic finding to assess 
the concurrent validity, 74.6% (85/114)children with normal CXR had 
AIOS of ≤10 whereas only 47.8%(64/) had normal scores in the group of 
abnormal CXR finding(χ2=29.1 P=0.001). On the other hand, severity of 
respiratory distress was similar between children with normal and 
abnormal chest radiographs. 
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Table.17 AIOS correlation with chest X ray 
Chest X-ray 
AIOS score on day 1 
≤10 11-15 ≥16 
n % n % n % 
abnormal 64 47.8 21 15.7 49 36.6 
normal 85 74.6 20 17.5 9 7.9 
 
χ2=29.1 P=0.001 
 
7. AIOS score and physical signs in pneumonia 
 
Respiratory morbidity of affected children were also stratified by 
their illness severity scores at presentation. Children scoring abnormally on 
AIOS (>10) had significantly higher frequency of severe tachypnea 
(p=0.001), marked recession (p=0.001), grunting, cyanosis (p=0.01), 
lethargy, inability to drink and so on except incidence of convulsion and 
wheeze which didn’t have any statistical significance 
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Table.18 univariate analysis of AIOS with respiratory morbidity signs 
 
  
AIOS_Day1 
Total Chi square test <=10 11-15 >15
n % n % n % 
Respiratory 
rate/mt 
  
  
40 -50 67 85.9% 8 10.3% 3 3.8% 78 χ2=56.0 
P=0.001 
 
51 -60 67 55.8% 26 21.7% 27 22.5% 120 
>60 15 30.0% 7 14.0% 28 56.0% 50 
Intercostal recession 35 31.5% 22 19.8% 54 48.6% 111 χ2=83.4 
P=0.001 
 
 Sub costal 
recession 
  
Mild-
moderate 
102 76.7% 25 18.8% 6 4.5% 133 χ2=111.1 
P=0.001 
 severe 16 19.8% 16 19.8% 49 60.5% 81 
Grunt         16 100.0% 16 χ2=56.2 
P=0.001 
 
Cyanosis 1 16.7%     5 83.3% 6 χ2=12.3 P=0.01 
 
Lethargy 8 12.3% 10 15.4% 47 72.3% 65 χ2=123.3 
P=0.001 
 
Convulsion 4 40.0% 1 10.0% 5 50.0% 10 χ2=4.1 
P=0.13NS          
 
inability to drink 1 2.7% 3 8.1% 33 89.2% 37 χ2=106.2 
P=0.001 
 
 Abnormal Capillary 
refill time(>2 sec) 
2 6.7%     28 93.3% 30 χ2=93.2 
P=0.001 
 
  Decreased breath 
sounds 
    4 36.4% 7 63.6% 11 χ2=17.6 
P=0.001 
 
Bronchial breathing     3 21.4% 11 78.6% 14 χ2=28.5 
P=0.001 
 
Crepitations 
 
126 56.0% 41 18.2% 58 25.8% 225 χ2=16.8 
P=0.001 
 
Wheeze 52 54.2% 21 21.9% 23 24.0% 96 χ2=3.6 P=0.16     
NS 
 
 Vocal 
resonance 
  
Decreased 1 16.7% 2 33.3% 3 50.0% 6 χ2=25.3 
P=0.001 
 
increased         6 100.0% 6 
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8. AIOS and pulse oxymetre correlation 
Relating children’s score against their pulse ox meter recording on 
admission, severe hypoxemia associated with cyanosis (SpO2<85) was 
observed in 14 children of which 92.9% (13) scored a high value on AIOS 
(AIOS>15) whereas 81.5% of children scored normally on AIOS among 
the group of 135 with a spo2>92. 
Table.19 AIOS correlation with SpO2 reading 
SpO2reading(%) 
AIOS score on day1 
≤10 11-15 ≥16 
n % n % n % 
<85 1 7.1 0 0 13 92.9 
85-92 38 38.4 25 25.3 36 36.4 
>92 110 81.5 16 11.9 9 6.7 
χ2=85.4 P=0.001 
9. AIOS score and investigations 
74.6% (85/114) children with normal CXR had AIOS of ≤10 
whereas only 47.8 %( 64/) had normal scores in the group of abnormal 
CXR finding (χ2=29.1 P=0.001). Total leucocytes count, urine and blood 
culture were done in all patients to find out illness severity. Culture 
positivity in urine and blood cultures as well as an elevated leucocytes 
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count was seen in maximum percentage in children scoring >15 in AIOS 
scale which was statistically significant. 
Table.20 AIOS correlation with investigations 
 
investigations 
AIOS score on day 1 Chi 
square 
test 
≤10 11-15 ≥16 
n % n % n % 
Chest X ray 
abnormal 64 47.8 21 15.7 49 36.6 χ2=29.1 
P=0.001 
 normal 
85 74.6 20 17.5 9 7.9 
X ray 
Finding 
consolidation 8 15.1 11 20.8 34 64.2 χ2=38.5 
P=0.001 infiltrates 55 68.8 10 12.5 15 18.8 
Leucocytosis 5 14.7 5 14.7 24 70.6 χ2=51.2 P=0.001 
Positive Blood culture 0 0 3 8.8 31 91.2 χ2=102.2 P=0.001 
Positive Urine culture 4 13.3 5 16.7 21 70.0 χ2=44.1 P=0.001 
 
 
10. AIOS score and therapeutic decision 
Univariate analysis was done to know the relationship of AIOS with 
therapeutic decision, except for salbutamol nebulization all other 
therapeutic modalities were significantly related to initial AIOS score 
(p=0.001) 
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Table.21 univariate analysis of AIOS with therapeutic decision 
 
Therapeutic 
decision(n)  
  
AIOS_Day1  
Statistical 
significance 
≤10 11-15 ≥16 
n 
( %) 
n 
(%) 
n 
(%) 
antibiotic 
  
Oral(123) 114 
(92.7%)
8 
(6.5%)
1 
(0.8%)
 
χ2=111.9 P=0.001 
 I.V(125) 35 
(28.0%)
33 
(26.4%)
57 
(45.6%)
IV fluid received(71) 
 
3 
(4.2%) 
15 
(21.1%) 
53 
(74.6%) 
χ2=164.0 P=0.001 
 
Normal saline 
bolus(21) 
0 
(0%) 
0 
(0 %) 
21 
(100.0%)
χ2=75.2 P=0.001 
 
Ionotropes(19) 0 
(0%) 
0 
(0%) 
19 
(100.0%)
χ2=67.4P=0.001 
Ventilation 
 (7) 
0 
(0%) 
0 
(0%) 
7 
(100.0%)
χ2=23.5 P=0.001 
Oxygen(80) 5 
(6.3%) 
22 
(27.5%) 
53 
(66.3%) 
χ2=158.3 P=0.001 
Nebulisation(63) 35 
(55.6%)
16 
(25.4%) 
12 
(19.0%) 
χ2=4.98 P=0.08  NS 
Intercostals drainage(9) 0 
(0%) 
4 
(44.4%) 
5 
(55.6%) 
χ2=14.1 P=0.001 
decortications(3) 0 
(0%) 
3 
(100.0%)
0 
(0%) 
χ2=15.3 P=0.001 
 
 
Comparison of AIOS with IMNCI in illness severity assessment and 
clinical outcome in pneumonia 
1. Illness severity assessment 
Comparing AIOS with IMNCI in assessing illness severity of 
pneumonia , among the 73 cases of pneumonia 95.9% cases scored normal 
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on AIOS (AIOS<10),whereas in 56 cases of very severe disease 
80.4%(45)cases scored abnormally. 
Table.22 comparison of AIOS with IMNCI in illness severity assessment 
 
IMNCI 
 
AIOS_Day1 
≤10 11-15 ≥16 
n % n % n % 
Pneumonia(73) 70 95.9% 2 2.7% 1 1.4% 
 Severe pneumonia(119) 76 63.9% 31 26.1% 12 10.1%
 Very severe pneumonia(56) 3 5.4% 8 14.3% 45 80.4%
           χ2=160.72 P=0.001 
Comparing with IMNCI sensitivity of AIOS in detecting illness   
severity in pneumonia was very high (95%) but with a poor specificity 
(55%), where as in very severe pneumonia its sensitivity was poor (48%) 
but had very high specificity (98%). In case of severe pneumonia both 
sensitivity and specificity of AIOS score was very poor 
Table.23 sensitivity and specificity of AIOS 
 
 
IMNCI 
AIOS 
sensitivity specificity accuracy 
pneumonia 95%(88-99) 55%(47-62) 67%(60-72) 
severe pneumonia 51%(43-59) 57%(46-57) 53%(47-60) 
very severe pneumonia 48%(39-58) 98%(94-100) 77%(72-82) 
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2. Clinical outcome 
 
Persistent distress on day5 
 
Among the 148 who scored AIOS<10 only 2.02% had mild –
moderate distress persisting on day5, while out of the 41 who scored 11-55 
on AIOS  7.31% had mild –moderate distress persisting. In the worst group 
of AIOS score, out of the 54 cases 3.7%had severe retraction and 33.3% 
had mild to moderate distress persisting on day5      
Table.24 AIOS in predicting persistent distress on day5 
AIOS 
Persistent distress on day 5 total Chi-square test 
no Mild-moderate severe  
 
 
 
 
χ2=98.6 
P=0.001 
 
≤10 n 145 3 0 148
% 97.97 2.02 0  
11-15 N 38 3 0 41
% 92.68 7.31 0
≥16 N 34 18 2 54
% 62.96 33.33 3.70  
 
In the IMNCI classification of respiratory illness, among the 
pneumonia cases none had persistent distress on day5. In the severe 
pneumonia group 4.4% had mild-moderate distress and only 0.6% had 
severe persistent distress. In the very severe pneumonia group 33.3% had 
mild to moderate distress and 2% had severe distress persisting on day5 
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Table.25 IMNCI in predicting persistent distress on day 5 
 
IMNCI 
 
Persistent distress on day5 
Chi-
square 
test 
no Mild-moderate severe 
n % n % n % 
Pneumonia(33) 33 100%         
χ2=42.09 
p=0.001 
significant 
 Severe pneumonia(159) 151 95.0% 7 4.4% 1 0.6% 
 Very severe 
pneumonia(56) 33 64.7% 17 33.3% 1 2.0% 
 
Complications 
Complications were absent in those who scored <10, while 
maximum complications were seen in those who scored >15. Similarly in 
the IMNCI classification complications were absent in pneumonia cases 
and maximum in very severe pneumonia cases 
Table.26 AIOS in predicting complications 
AIOS complications total 
Chi square 
test 
present absent   
 
 
χ2=84.1 
P=0.001 
 
≤10 N 0 150 150 
% 0 100  
11-15 N 4 37 41 
% 9.75 90.24  
≥16 N 20 37 57
% 35.08 64.91  
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Table.27 IMNCI in predicting complications 
 
IMNCI 
complications 
n  Chisquaretestpresent absent 
n % n % 
pneumonia 0 0 34  100  34 
χ2=73.95 
p=0.001 
significant 
 Severe 
pneumonia 5 3.1 154 96.9 159 
Very severe 
pneumonia 19 34.5 
36 
  
65.% 
  55 
Table Total 28 9.7 223 90.3 248 
 
 
Hospital stay 
Out of the 149 who scored <10 on AIOS 95.3% had a hospital stay 
of <5 days, while those scored the worst 48.3% had a stay duration of 6-14 
days and 20.7% had >14 days hospital stay duration. In the IMNCI groups 
hospital stay was more prolonged in very severe and severe pneumonia 
groups 
Table.28 AIOS in predicting duration of hospital stay 
AIOS 
Duration of hospital stay  (in 
days) total 
Chi square 
test 
≤5 6-14 >14  
 
 
χ2=46.7 
P=0.001 
 
≤10 n 142 6 1 149 
% 95.30 4.02 0.67  
11-15 N 31 8 2 41 
% 75.60 19.51 4.87  
≥16 N 18 28 12 58 
% 31.03 48.27 20.68  
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Table.29 IMNCI in predicting duration of hospital stay 
 
IMNCI  
hospital stay 
n % <=5 days 6 -14 days >14 days
n  % n  % n  % 
pneumonia 32 97.0% 1 3.0%     33 
χ2=65.05 
p=0.001 
significant
  
Severe pneumonia 
138 86.8% 15 9.4% 6 3.8% 159 
 Very severe 
pneumonia 21 37.5% 26 46.4% 9 16.1% 56 
 
Final outcome 
Regarding the final outcome death was seen only in those who 
scored >15 on AIOS (8.62%). Similarly IMNCI also predicted death in 
very severe disease. 
 
Table.30 AIOS in predicting final outcome 
AIOS Final outcome total 
Chi square 
test 
died discharged   
 
 
χ2=16.71 
P=0.001 
 
≤10 n 0 149 149 
% 0 100  
11-15 N 0 41 41 
% 0 100  
≥16 N 5 53 58 
% 8.62 91.37
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Table.31 IMNCI in predicting final outcome 
 
 
 
IMNCI 
Final outcome 
Chi square test died discharged 
n % n % 
Pneumonia(33) 
    33 100.0%
χ2=17.49 
p=0.001 
significant 
  
Severe pneumonia(159)     159 100.0%
  
Very severe pneumonia(56) 
5 8.9% 51 91.1% 
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DISCUSSION 
Childhood pneumonia clearly represents one of the most common 
infective illnesses in developing countries and is of great importance as a 
cause of preventable mortality in children. To attack this global problem, 
WHO shaped strategy for effective case management that had remarkable 
impact on mortality due to childhood pneumonia in developing countries. 
Most of the presenting symptoms in young infants and children may be 
associated with different illness or more than one illness. Therefore for 
early detection and prompt treatment of illness   there is need for an 
effective strategy that target children less than 5 years old, the age group 
that bears highest burden on death.  This has been aided by the IMNCI 
strategy that simplifies the classification of illness severity for major acute 
childhood illness including pneumonia. 
IMNCI strategy will be more effective in managing pneumonia 
when supplemented by an illness severity scoring system delivered in the 
context to primary care setting that can quantity quickly the severity of 
illness at all stages from onset to recovery. The present study was done 
with this view in mind. The objective of this study was to validate AIOS 
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score in community acquired pneumonia in assessing illness severity and 
clinical outcome. 
  The compromised general status entailing various observation 
variables of AIOS had already shown to be significant and independent 
predictor of serious illnesses. Being a subjective score inter observer 
variation in scoring was analyzed using Karl Pearson correlation and was 
found to be having high positive correlation. 
Validating the score in illness severity assessment in pneumonia, it 
was found that the scoring is having good sensitivity but with a poor 
specificity in pneumonia and in severe pneumonia it had a good specificity 
but a poor sensitivity. In severe pneumonia it had a poor sensitivity and 
specificity in diagnosing pneumonia compared to IMNCI. So IMNCI is 
still the superior sensitive tool in classification of pneumonia. Though the 
internal consistency and external validity of AIOS scoring system is very 
high as proven by our study its utility as a sensitive tool in diagnosing 
severe illnesses should be restricted to those presenting with febrile illness 
that present without any focus of infection. 
This study has brought out the fact that AIOS scoring has a good 
correlation with initial pulse oxymetre reading and decision regarding 
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supplementation of oxygen. So it can be used as a tool to decide on 
providing oxygen to patients in resource limited areas. 
AIOS scoring also had a good correlation with X ray abnormalities 
so can be utilized to decide on x ray evaluation and preventing unnecessary 
exposure to harmful radiations in a child with pneumonia. 
AIOS also correlated well with initial therapeutic decision like route 
of antibiotics, need for intravenous fluid administration and other 
modalities, so can be used for the same purpose in a hospital 
Comparing the ability of AIOS score to predict clinical outcome 
with that of IMNCI both were found to be more or less equally predictive. 
Regarding the persistence of respiratory distress on day 5 of hospital stay 
severe distress was present in 3.7% of those children scored AIOS≥16 and 
in IMNCI very severe pneumonia group 2% had same finding and both of 
them were statistically significant.  
Similarly on predicting complications maximum numbers of 
complications were present in those with AIOS score ≥16 (35%) and in 
very severe group in IMNCI (34.5%) which were almost equal. 
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 Both IMNCI and AIOS predicted the length of hospital stay in a 
similar manner with maximum duration of stay in those with a worst AIOS 
score and very severe illness. 
Regarding final out-come all the deaths occurred in the worst AIOS 
score group (8.6%) and in the very severe pneumonia group in IMNCI 
(8.9%) which were also similar. 
Though AIOS can predict clinical outcome in children with 
pneumonia it is not superior to IMNCI in same regards. AIOS scoring is 
usually done by a skilled physician familiar with behavior of a child in 
varying degrees of illness severity in the hospital setting where as IMNCI 
classification of pneumonia is done by peripheral health workers in the 
field setting. So AIOS scoring can be used by the treating physician in 
deciding on therapeutic modalities and prognosticating a child admitted to 
the hospital with pneumonia. 
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SUMMARY AND CONCLUSIONS 
 
• AIOS scoring has good internal consistency and external validity. 
• Inter observer agreement between two observers in AIOS scoring is 
very good. 
• AIOS scoring cannot be used as a sensitive tool to classify illness 
severity in pneumonia. 
• IMNCI remains the more sensitive tool in illness severity 
classification in pneumonia. 
• AIOS correlates well with abnormal X ray findings and other 
investigations and therapeutic decision taken by the physician. 
• AIOS has good correlation with initial SpO2 reading.  
• Both IMNCI and AIOS predict clinical outcome similarly in 
community acquired pneumonia. 
• IMNCI can be used as a tool to triage and early referral of children 
with community acquired pneumonia in the fields by peripheral 
health care workers. 
• AIOS can be used as a tool to decide on therapeutic modalities and 
prognosticating a child with pneumonia admitted to the hospital by a 
physician 
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ANNEXURE 
DATA COLLECTION FORM 
 
Name:                                                DOA:                                                               
IP NO: 
Age:                                                    DOD:                                                                
weight: 
Sex: 
Complaints with duration 
Fever 
Cough 
Rapid/difficult breathing 
Convulsion 
Inability to drink 
Lethargy 
Grunt 
Signs 
 
parameters Day1 Day2 Day5 
Respiratory rate    
Temperature    
Heart rate    
Blood pressure    
Capillary refill time    
lethargy    
Cyanosis    
Grunting    
Stridor    
Retraction    
Intercostals    
Sub costal  
Mild-moderate 
Severe 
   
   
   
Breath sounds    
Bronchial breathing    
Crackles    
Vocal resonance    
Wheeze    
IMNCI class    
SpO2 reading    
AIOS scoring    
 
Radiological findings: present/absent 
Type: end point consolidation/non end point infiltrates 
CBC 
Other investigations:             urine c/s                           NEC 
Treatment given: antibiotic- oral/i.v       oxygen    i.v fluids   others 
Complications  
 
 
 
 
 
 
 
ACUTE ILLNESS OBSERVATION SCALE 
observation 
item 
normal (=1) moderate 
impairment 
(=3) 
severe impair 
(=5) 
D1 D2 D5
1.quality of 
cry 
strong with 
normal 
crying 
 
Whimpering 
or 
sobbing and 
not crying 
Weak or 
moaning 
Or high-pitched  
   
2. Reaction to 
Parent 
Stimulation 
(effect on 
crying When 
Held, patted 
on back 
Jiggled on 
lap, or 
Carried) 
Cries 
briefly, 
Then stops 
Or Content 
and Not 
crying 
Cries off And 
on 
Continual cry 
Or Hardly 
respond 
   
3.State 
Variation 
(going from 
awake To 
asleep or 
asleep To 
awake) 
If awake, 
then Stays 
awake Or If 
asleep and 
Stimulated, 
then Wakes 
up quickly.
Eyes-close 
Briefly, Then 
awakens Or 
Awakens 
with, 
Prolonged 
Stimulation
Will not rouse 
Or Falls to 
sleep 
   
4. Color Pink Pale hands, 
Feet  Or 
Acrocyanosis  
Pale Or Blue Or 
Ashen (gray) 
Or 
Mottled 
   
5. Hydration 
(moisture in 
Skin, eyes, 
mouth) 
Skin normal 
And 
Eyes, Mouth 
moist 
Skin, eyes 
Normal; And 
 mouth 
slightly Dry 
Skin doughy Or 
tented And 
Eyes may be 
sunken And   
Dry eyes and 
mouth
   
6. Response  
To social 
overtures 
 
Smiles Or 
Alerts ( 2 
months or  
Less) 
Brief smile Or 
Alerts briefly 
(2 months or  
Less) 
No smile, Face 
anxious Or Dull 
Expressionless 
Or No 
Alerting(2 
Months or  
Less)
   
 
 
 
